GlucoTrack Shares to Reverse Split on Monday, August 31st (NASDAQ:GCTK)

GlucoTrack, Inc. (NASDAQ:GCTK)’s stock is scheduled to reverse split before the market opens on Monday, August 31st. The 1-15 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, August 30th.

GlucoTrack Trading Down 10.9%

Shares of GlucoTrack stock traded down $0.03 during midday trading on Thursday, reaching $0.29. The company had a trading volume of 1,670,509 shares, compared to its average volume of 6,231,775. The stock has a fifty day moving average price of $0.39 and a 200 day moving average price of $0.75. GlucoTrack has a fifty-two week low of $0.25 and a fifty-two week high of $14.14. The firm has a market cap of $2.21 million, a PE ratio of -0.03 and a beta of 0.70. The company has a debt-to-equity ratio of 0.08, a current ratio of 0.46 and a quick ratio of 0.46.

GlucoTrack (NASDAQ:GCTK) last announced its earnings results on Friday, August 14th. The company reported $0.76 EPS for the quarter.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on GCTK shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of GlucoTrack in a research report on Friday, July 17th. Wall Street Zen upgraded shares of GlucoTrack from a “strong sell” rating to a “sell” rating in a report on Saturday, August 8th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

Hedge Funds Weigh In On GlucoTrack

Several institutional investors have recently added to or reduced their stakes in the business. Ikarian Capital LLC acquired a new position in GlucoTrack in the fourth quarter valued at approximately $177,000. Boothbay Fund Management LLC acquired a new stake in shares of GlucoTrack during the 4th quarter worth approximately $52,000. Finally, Bank of America Corp DE increased its stake in shares of GlucoTrack by 102,125.0% in the 2nd quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock valued at $25,000 after acquiring an additional 4,085 shares in the last quarter. 10.92% of the stock is owned by institutional investors and hedge funds.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.